Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 28;3(3):e000669.
doi: 10.1161/JAHA.113.000669.

Delay in filling first clopidogrel prescription after coronary stenting is associated with an increased risk of death and myocardial infarction

Affiliations

Delay in filling first clopidogrel prescription after coronary stenting is associated with an increased risk of death and myocardial infarction

Nicholas L Cruden et al. J Am Heart Assoc. .

Abstract

Background: Patients frequently experience difficulties with medication compliance after hospital discharge. We investigated the effect of a delay in filling a first clopidogrel prescription after hospital discharge on clinical outcomes subsequent to coronary stenting.

Methods and results: Hospital administrative, community pharmacy, and cardiac revascularization data were determined for all patients receiving a coronary stent in British Columbia 2004-2006 with follow-up out to 2 years. Cox's proportional hazard regression analysis, adjusting for baseline demographics and procedural variables, was performed to examine the effects of delay in filling a clopidogrel prescription after hospital discharge on clinical outcomes.Of 15 629 patients treated with coronary stents, 3599 received at least 1 drug-eluting stent (DES), whereas 12 030 received bare metal stents (BMS) alone. In total, 1064 (30%) and 3758 (31%) patients in the DES and BMS groups, respectively, failed to fill a prescription within 3 days of discharge (median, 1 day; interquartile range [IQR], 1 to 3). After regression analysis, a delay of >3 days was predictive of mortality and recurrent myocardial infarction (MI) irrespective of stent type (DES: hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.7 to 3.4; and HR, 2.0; 95% CI, 1.5 to 2.7, respectively, and BMS: HR, 2.2; 95% CI, 1.9 to 2.6; and HR, 1.8; 95% CI, 1.5 to 2.1, respectively). This excess hazard was greatest in the 30-day period immediately after hospital discharge (mortality: HR, 5.5; 95% CI, 3.5 to 8.6; and MI: HR, 3.1; 95% CI, 2.4 to 4.0, for all patients).

Conclusions: Delays in patients filling their first prescription for clopidogrel after coronary stenting are common and associated with adverse clinical outcomes, irrespective of stent type. Strategies to reduce delays have the potential to improve clinical outcomes.

Keywords: clopidogrel; death; myocardial infarction; percutaneous coronary intervention.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Frequency of delay in filling a first community prescription for clopidogrel in the 30 days after hospital discharge.
Figure 2.
Figure 2.
Risk‐adjusted mortality (upper panels) and readmission for myocardial infarction (lower panels) for patients treated with drug‐eluting (DES) or bare metal (BMS) coronary stents stratified by time to fill a first community prescription for clopidogrel after coronary stent implantation (≤3 days [solid blue line] versus >3 days [solid green line]). BMS indicates bare metal stent; DES, drug‐eluting stent; PCI, percutaneous coronary intervention.
Figure 3.
Figure 3.
Risk‐adjusted mortality (left panel) and readmission for myocardial infarction (right panel) in the immediate period after hospital discharge (4 to 30 days) for patients treated with any coronary stent stratified by time to fill a first community prescription for clopidogrel (≤3 days [solid blue line] versus >3 days [solid green line]).

Similar articles

Cited by

References

    1. Kripalani S, Price M, Vigil V, Epstein KR. Frequency and predictors of prescription‐related issues after hospital discharge. J Hosp Med. 2008; 3:12-19. - PubMed
    1. Cua YM, Kripalani S. Medication use in the transition from hospital to home. Ann Acad Med Singapore. 2008; 37:136. - PMC - PubMed
    1. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug‐eluting stents. JAMA. 2005; 293:2126-2130. - PubMed
    1. Ho PM, Tsai TT, Maddox TM, Powers JD, Carroll NM, Jackevicius C, Go AS, Margolis KL, DeFor TA, Rumsfeld JS, Magid DJ. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug‐eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010; 3:261-266. - PubMed
    1. Sheehy O, LeLorier J, Rinfret S. Restrictive access to clopidogrel and mortality following coronary stent implantation. CMAJ. 2008; 178:413-420. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources